BMJ Oncology

BMJ Publishing Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

BMJ Oncology is an open-access journal published by BMJ Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,390 GBP. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMJ Publishing Group
ISSN
2752-7948
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,390 GBP
Articles in DOAJ
235
Declared review time
18 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2024-05-29
Indexing
DOAJ
APC
2,390 GBP
Declared review time (DOAJ)
18 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

235

Most recent article

last month

Average review time (journal-declared via DOAJ)

18weeks

Works in OpenAlex

224

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

15

i10-index

30

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2024-05-29
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PorticoLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
98%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918646275006676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
Show all subjects (50)
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Cancer survivorship and care
  • Lung Cancer Treatments and Mutations
  • Cancer survivorship and care
  • Lung Cancer Treatments and Mutations
  • Prostate Cancer Treatment and Research
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Treatments and Studies
  • Artificial Intelligence in Healthcare and Education
  • Artificial Intelligence in Healthcare and Education
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Screening and Detection
  • Cervical Cancer and HPV Research
  • CAR-T cell therapy research
  • Cervical Cancer and HPV Research
  • CAR-T cell therapy research
  • Ethics in Clinical Research
  • Bladder and Urothelial Cancer Treatments
  • Ethics in Clinical Research
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Head and Neck Cancer Studies
  • Ferroptosis and cancer prognosis
  • Cancer Risks and Factors
  • Head and Neck Cancer Studies
  • Prostate Cancer Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Cancer Risks and Factors
  • Ferroptosis and cancer prognosis

Keywords (DOAJ)

  • cancer
  • cancer research
  • translational medicine
  • oncology
  • tumors
  • neoplasms

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: